Rizzoli R, Bruyere O, Cannata-Andia J B, Devogelaer J -P, Lyritis G, Ringe J D, Vellas B, Reginster J -Y
Division of Bone Diseases, Department of Rehabilitation and Geriatrics, Geneva University Hospitals and Faculty of Medicine, Rue Micheli-du-Crest 24, 1211, Geneva 14, Switzerland.
Curr Med Res Opin. 2009 Oct;25(10):2373-87. doi: 10.1185/03007990903169262.
Osteoporosis is predominantly a condition of the elderly, and the median age for hip fracture in women is approximately 83 years. Osteoporotic fracture risk is multifactorial, and often involves the balance between bone strength and propensity for falling.
To present an overview of the available evidence, located primarily by Medline searches up to April, 2009, for the different management strategies aimed at reducing the risk of falls and osteoporotic fractures in the elderly.
Frailty is an independent predictor of falls, hip fractures, hospitalisation, disability and death in the elderly that is receiving increasing attention. Non-pharmacological strategies to reduce fall risk can prevent osteoporotic fractures. Exercise programmes, especially those involving high doses of exercise and incorporating balance training, have been shown to be effective. Many older people, especially the very elderly and those living in care institutions, have vitamin D inadequacy. In appropriate patients and given in sufficient doses, vitamin D and calcium supplementation is effective in reducing both falls and osteoporotic fractures, including hip fractures. Specific anti-osteoporosis drugs are underused, even in those most at risk of osteoporotic fracture. The evidence base for the efficacy of most such drugs in the elderly is incomplete, particularly with regard to nonvertebral and hip fractures. The evidence base is perhaps most complete for the relatively recently introduced drug, strontium ranelate. Non-adherence to treatment is a substantial problem, and may be exacerbated by the requirements for safe oral administration of bisphosphonates.
Evidence-based strategies are available for reducing osteoporotic fracture risk in the elderly, and include exercise training, vitamin D and calcium supplementation, and use of evidence-based anti-osteoporotic drugs. A positive and determined approach to optimising the use of such strategies could reduce the burden of osteoporotic fractures in this high-risk group.
骨质疏松症主要是一种老年疾病,女性髋部骨折的中位年龄约为83岁。骨质疏松性骨折风险是多因素的,通常涉及骨强度与跌倒倾向之间的平衡。
主要通过截至2009年4月的医学文献数据库检索,概述针对降低老年人跌倒和骨质疏松性骨折风险的不同管理策略的现有证据。
衰弱是老年人跌倒、髋部骨折、住院、残疾和死亡的独立预测因素,正受到越来越多的关注。降低跌倒风险的非药物策略可预防骨质疏松性骨折。运动计划,尤其是那些涉及高强度运动并包含平衡训练的计划,已被证明是有效的。许多老年人,尤其是高龄老人和住在护理机构的人,维生素D不足。在合适的患者中给予足够剂量时,补充维生素D和钙可有效降低跌倒和骨质疏松性骨折的发生率,包括髋部骨折。特定的抗骨质疏松药物未得到充分利用,即使在骨质疏松性骨折风险最高的人群中也是如此。大多数此类药物在老年人中疗效的证据基础不完整,尤其是在非椎体和髋部骨折方面。对于相对较新推出的药物雷奈酸锶,证据基础可能最为完整。不坚持治疗是一个严重问题,双膦酸盐安全口服给药的要求可能会加剧这一问题。
有基于证据的策略可降低老年人骨质疏松性骨折风险,包括运动训练、补充维生素D和钙,以及使用基于证据的抗骨质疏松药物。积极且坚定地优化这些策略的使用方法可减轻这一高危人群骨质疏松性骨折的负担。